Induced pluripotent stem cell (iPSC) culture and transfection represents critical enabling technology for cell therapy development. Our optimized protocols achieve high cell viability, pluripotency maintenance, and transfection efficiency supporting downstream differentiation and therapeutic applications.

Culture optimization focuses on media composition, substrate selection, and culture parameters. Defined serum-free media maintain pluripotency while improving reproducibility. Feeder-free culture systems enable scalability. Temperature and pH monitoring ensures optimal culture conditions.

Passaging strategies maintain culture health and prevent differentiation. Standard protocols minimize cell damage and optimize recovery. Quality control testing confirms pluripotency markers through flow cytometry and gene expression analysis.

Transfection methodology selection depends on downstream applications. Nucleofection achieves high efficiency (>70%) but requires optimization for cell type. Viral vector transduction enables stable integration for long-term gene expression. Lipofection offers gentler approach with lower efficiency.

Post-transfection optimization includes recovery time, selection strategies, and quality assessment. Viability monitoring ensures acceptable post-transfection survival (>60%). Gene expression verification confirms successful transfection.

Differentiation protocols enable directed differentiation toward therapeutic cell types. Differentiation efficiency monitoring ensures quality of therapeutic cells. Functional characterization validates therapeutic potential.

Translational applications include autologous cell therapy for cancer immunotherapy, patient-specific cell replacement therapy, and disease modeling. Clinical success depends on robust manufacturing protocols and quality assurance systems.